Old Web
English
Sign In
Acemap
>
authorDetail
>
Karl Yen
Karl Yen
Hoffmann-La Roche
Medicine
Dermatology
Placebo
Corticosteroid
Eczema Area and Severity Index
2
Papers
173
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A Phase 1b/2 Study of the Anti-Myostatin Adnectin RG6206 (BMS-986089) in Ambulatory Boys with Duchenne Muscular Dystrophy: A 72-Week Treatment Update (P1.6-062)
2019
Neurology
Kathryn R. Wagner
Brenda L. Wong
Barry J. Byrne
C. Tian
Leslie K. Jacobsen
Giridhar Tirucherai
Michael Rabbia
Heidemarie Kletzl
Juergen Dukart
Rose Ong
Karl Yen
G. Sajeev
James Signorovitch
Susan Ward
Cliff Bechtold
Michelle L. Krishnan
Show All
Source
Cite
Save
Citations (4)
Efficacy and safety of lebrikizumab (an anti-IL-13 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical corticosteroids: A randomized, placebo-controlled phase II trial (TREBLE)
2018
Journal of The American Academy of Dermatology
Eric L. Simpson
Carsten Flohr
Lawrence F. Eichenfield
Thomas Bieber
Howard Sofen
A. Taieb
Ryan Owen
Wendy S. Putnam
Marcela Castro
Kendra DeBusk
Chin Yu Lin
Athina Voulgari
Karl Yen
Theodore A. Omachi
Show All
Source
Cite
Save
Citations (169)
1
map